Role
10%+ Owner
Signature
By: Bellevue Capital Management LLC, Its Manager /s/ Kuk Hyoun Hwang, Managing Member
Stock symbol
BLAC
Transactions as of
Feb 14, 2023
Transactions value $
$8,600,000
Form type
4
Date filed
2/16/2023, 06:52 PM
Previous filing
Feb 9, 2023
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLAC Common Stock Other $0 -20K -1.16% $0.00 1.71M Feb 14, 2023 Direct F1, F2
transaction BLAC Common Stock Other $0 -20K -1.17% $0.00 1.69M Feb 14, 2023 Direct F1, F3
transaction BLAC Common Stock Other $0 -20K -1.19% $0.00 1.67M Feb 14, 2023 Direct F1, F4
transaction BLAC Common Stock Other $0 -20K -1.2% $0.00 1.65M Feb 14, 2023 Direct F1, F5
transaction BLAC Common Stock Other $0 -20K -1.22% $0.00 1.63M Feb 14, 2023 Direct F1, F6
transaction BLAC Common Stock Other $0 -225K -13.85% $0.00 1.4M Feb 14, 2023 Direct F1, F7
transaction BLAC Common Stock Other $0 -30K -2.14% $0.00 1.37M Feb 14, 2023 Direct F1, F8
transaction BLAC Common Stock Award $4.3M +430K +31.39% $10.00 1.8M Feb 14, 2023 Direct F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLAC Private Placement Warrants Purchase $4.3M +430K $10.00 430K Feb 14, 2023 Common Stock 430K $11.50 Direct F10
transaction BLAC Warrant for Common Stock Other $0 -20K -4.65% $0.00 410K Feb 14, 2023 Common Stock 20K $11.50 Direct F11
transaction BLAC Warrant for Common Stock Other $0 -20K -4.88% $0.00 390K Feb 14, 2023 Common Stock 20K $11.50 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor") whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
F2 Represents the shares transferred by the Sponsor to Mr. Jin Whan Park for his board service.
F3 Represents the shares transferred by the Sponsor to Mr. Steven Reed for his board service.
F4 Represents the shares transferred by the Sponsor to Mr. In Chul Chung for his board service.
F5 Represents the shares transferred by the Sponsor to Mr. Husun Euh for his board service.
F6 Represents the shares transferred by the Sponsor to Mr. Rad Roberts for his board service.
F7 Represents the shares that were forfeited as a result of the underwriters' not exercising their over-allotment option.
F8 Represents the shares transferred by the Sponsor to the underwriters.
F9 The Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement that occurred simultaneously with the consummation of the Issuer's Public Offering. Each Private Placement Unit consists of one share of Common Stock, one redeemable warrant entitling the holder to purchase one share of Common Stock, and one right which entitles the holder thereof to receive one-tenth (1/10) of a share of common stock.
F10 The Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement that occurred simultaneously with the consummation of the Issuer's Public Offering. Each Private Placement Unit consists of one share of Common Stock, one redeemable warrant entitling the holder to purchase one share of Common Stock, and one right which entitles the holder thereof to receive one-tenth (1/10) of a share of common stock. The Private Placement Warrants are exercisable only to purchase whole shares of Common Stock at an exercise price of $11.50 per share, subject to adjustments. Each warrant will become exercisable 30 days after the Issuer's Public Offering. Each warrant will expire five years after the completion of the Issuer's Public Offering, or earlier upon redemption or liquidation.
F11 Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Dr. In Chul Chung for his service as Chairman of the Audit Committee.
F12 Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. Steven Reed for his service as Chairman of the Board of Directors.